BackOmega Therapeutics Overview

Omega Therapeutics Current Cash

Track Omega Therapeutics's current cash ($30M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$30.38M
62.85% YoYΔ $-51.39M vs prior year quarter

Peer average

Loading

Omega Therapeutics Current Cash History

Loading

Omega Therapeutics vs. peers: Current Cash Comparison

Loading

Omega Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Omega Therapeutics (OMGA) FAQ

The latest current cash for OMGA is $30M as of September 2024. That compares with $82M in the prior-year period — down 62.8% year over year. Investors often review this figure alongside Omega Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, OMGA's current cash moved from $82M to $30M — a 62.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Omega Therapeutics's operating scale or balance-sheet position.

A current cash figure of $30M for OMGA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OMGA's current cash ($30M), review year-over-year change from $82M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Omega Therapeutics's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.